Compare HHH & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HHH | HAE |
|---|---|---|
| Founded | 2010 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | 2023 | 1996 |
| Metric | HHH | HAE |
|---|---|---|
| Price | $70.06 | $118.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $84.00 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 680.1K | 607.7K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.82 | 0.72 |
| Revenue | ★ $1,474,892,000.00 | $910,373,000.00 |
| Revenue This Year | $70.68 | $6.21 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ $24.68 | $162.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.09 | $48.98 |
| 52 Week High | $91.07 | $123.77 |
| Indicator | HHH | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 64.22 |
| Support Level | $61.79 | $100.92 |
| Resistance Level | $74.76 | $123.77 |
| Average True Range (ATR) | 2.09 | 3.68 |
| MACD | -0.43 | -0.20 |
| Stochastic Oscillator | 47.15 | 77.24 |
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.